Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Haploidentical hematopoietic stem cell transplantation in adults using the αβTCR/CD19-based depletion of G-CSF-mobilized peripheral blood progenitor cells.

Prezioso L, Manfra I, Bonomini S, Schifano C, Segreto R, Monti A, Sammarelli G, Todaro G, Sassi M, Bertaggia I, Pelagatti L, Cambò B, Spolzino A, Follini E, Re F, Crugnola M, Craviotto L, Russo F, Plenteda C, Roti G, Giuliani N, Aversa F.

Bone Marrow Transplant. 2019 Aug;54(Suppl 2):698-702. doi: 10.1038/s41409-019-0608-z.

PMID:
31431717
2.

The transcriptomic profile of CD138+ cells from patients with early progression from smoldering to active multiple myeloma remains substantially unchanged.

Storti P, Agnelli L, Palma BD, Todoerti K, Marchica V, Accardi F, Sammarelli G, Deluca F, Toscani D, Costa F, Vicario E, Todaro G, Martella E, Neri A, Giuliani N.

Haematologica. 2019 Oct;104(10):e465-e469. doi: 10.3324/haematol.2018.209999. Epub 2019 Mar 7. No abstract available.

3.

Immune tolerance induction by nonmyeloablative haploidentical HSCT combining T-cell depletion and posttransplant cyclophosphamide.

Aversa F, Bachar-Lustig E, Or-Geva N, Prezioso L, Bonomini S, Manfra I, Monti A, Schifano C, Zlotnikov-Klionsky Y, Martelli MF, Sammarelli G, Sassi M, Soli M, Giuliodori S, Benecchi M, Giuliani N, Lohr F, Pratissoli S, Reisner Y.

Blood Adv. 2017 Oct 30;1(24):2166-2175. doi: 10.1182/bloodadvances.2017009423. eCollection 2017 Nov 14.

4.

Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma.

Dalla Palma B, Marchica V, Pedrazzoni M, Accardi F, Notarfranchi L, Goldoni M, De Luca F, Costa F, Storti P, Toscani D, Sammarelli G, Bonomini S, Aversa F, Giuliani N.

Br J Haematol. 2018 Dec;183(5):812-815. doi: 10.1111/bjh.15026. Epub 2017 Nov 16. No abstract available.

PMID:
29143308
5.

IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts.

Bolzoni M, Ronchetti D, Storti P, Donofrio G, Marchica V, Costa F, Agnelli L, Toscani D, Vescovini R, Todoerti K, Bonomini S, Sammarelli G, Vecchi A, Guasco D, Accardi F, Palma BD, Gamberi B, Ferrari C, Neri A, Aversa F, Giuliani N.

Haematologica. 2017 Apr;102(4):773-784. doi: 10.3324/haematol.2016.153841. Epub 2017 Jan 5.

6.

Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin?

Marchica V, Accardi F, Storti P, Mancini C, Martella E, Dalla Palma B, Bolzoni M, Todoerti K, Marcatti M, Schifano C, Bonomini S, Sammarelli G, Neri A, Ponzoni M, Aversa F, Giuliani N.

Int J Hematol. 2017 Jan;105(1):104-108. doi: 10.1007/s12185-016-2104-1. Epub 2016 Oct 3.

PMID:
27699576
7.

PML is required for telomere stability in non-neoplastic human cells.

Marchesini M, Matocci R, Tasselli L, Cambiaghi V, Orleth A, Furia L, Marinelli C, Lombardi S, Sammarelli G, Aversa F, Minucci S, Faretta M, Pelicci PG, Grignani F.

Oncogene. 2016 Apr 7;35(14):1876. doi: 10.1038/onc.2015.312. No abstract available.

PMID:
27052595
8.

Cryptic 13q34 and 4q35.2 Deletions in an Italian Family.

Riccardi F, Rivolta GF, Uliana V, Grati FR, La Starza R, Marcato L, Di Perna C, Quintavalle G, Garavelli L, Rosato S, Sammarelli G, Neri TM, Tagliaferri A, Martorana D.

Cytogenet Genome Res. 2015;147(1):24-30. doi: 10.1159/000442068. Epub 2015 Dec 9.

PMID:
26645620
9.

Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20.

Palma BD, Guasco D, Pedrazzoni M, Bolzoni M, Accardi F, Costa F, Sammarelli G, Craviotto L, De Filippo M, Ruffini L, Omedè P, Ria R, Aversa F, Giuliani N.

Leukemia. 2016 Feb;30(2):409-16. doi: 10.1038/leu.2015.259. Epub 2015 Sep 30.

PMID:
26419509
10.

ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non-small cell lung cancer patients.

Bozzetti C, Nizzoli R, Tiseo M, Squadrilli A, Lagrasta C, Buti S, Gasparro D, Zanoni D, Majori M, De Filippo M, Mazzoni F, Maddau C, Naldi N, Sammarelli G, Frati C, Pinto C, Ardizzoni A.

Diagn Cytopathol. 2015 Nov;43(11):941-6. doi: 10.1002/dc.23318. Epub 2015 Jul 7.

PMID:
26152804
11.

PML is required for telomere stability in non-neoplastic human cells.

Marchesini M, Matocci R, Tasselli L, Cambiaghi V, Orleth A, Furia L, Marinelli C, Lombardi S, Sammarelli G, Aversa F, Minucci S, Faretta M, Pelicci PG, Grignani F.

Oncogene. 2016 Apr 7;35(14):1811-21. doi: 10.1038/onc.2015.246. Epub 2015 Jun 29. Erratum in: Oncogene. 2016 Apr 7;35(14):1876.

12.

Implication of MAPK1/MAPK3 signalling pathway in t(8;9)(p22;24)/PCM1-JAK2 myelodysplastic/myeloproliferative neoplasms.

Masselli E, Mecucci C, Gobbi G, Carubbi C, Pierini V, Sammarelli G, Bonomini S, Prezioso L, Rossetti E, Caramatti C, Aversa F, Vitale M.

Br J Haematol. 2013 Aug;162(4):563-6. doi: 10.1111/bjh.12392. Epub 2013 May 24. No abstract available.

PMID:
23701125
13.

Overexpression of HOXB7 and homeobox genes characterizes multiple myeloma patients lacking the major primary immunoglobulin heavy chain locus translocations.

Agnelli L, Storti P, Todoerti K, Sammarelli G, Dalla Palma B, Bolzoni M, Rocci A, Piazza F, Semenzato G, Palumbo A, Neri A, Giuliani N.

Am J Hematol. 2011 Dec;86(12):E64-6. doi: 10.1002/ajh.22164. Epub 2011 Sep 22.

14.

EGFR and EML4-ALK gene mutations in NSCLC: a case report of erlotinib-resistant patient with both concomitant mutations.

Tiseo M, Gelsomino F, Boggiani D, Bortesi B, Bartolotti M, Bozzetti C, Sammarelli G, Thai E, Ardizzoni A.

Lung Cancer. 2011 Feb;71(2):241-3. doi: 10.1016/j.lungcan.2010.11.014. Epub 2010 Dec 18.

PMID:
21168933
15.

Bone osteoblastic and mesenchymal stromal cells lack primarily tumoral features in multiple myeloma patients.

Giuliani N, Lisignoli G, Novara F, Storti P, Zaffaroni N, Villa R, Sammarelli G, Agnelli L, Todoerti K, Bernardo ME, Manferdini C, Colla S, Abeltino M, Bolzoni M, Rocci A, Gabusi E, Palumbo A, Zuffardi O, Neri A, Rizzoli V.

Leukemia. 2010 Jul;24(7):1368-70. doi: 10.1038/leu.2010.96. Epub 2010 May 20. No abstract available.

PMID:
20485369
16.

A translocation t(4; 13)(q21;q14) as single clonal chromosomal abnormality in a parathyroid adenoma.

Sammarelli G, Zannoni M, Bonomini S, Delsignore R, Rizzoli V, Sianesi M, Caramatti C.

Tumori. 2007 Jan-Feb;93(1):97-9.

PMID:
17455879
17.

Interleukin-3 (IL-3) is overexpressed by T lymphocytes in multiple myeloma patients.

Giuliani N, Morandi F, Tagliaferri S, Colla S, Bonomini S, Sammarelli G, Rizzoli V.

Blood. 2006 Jan 15;107(2):841-2. No abstract available.

PMID:
16401825
18.

Lung cancer in patients with chronic lymphocytic leukemia: does the HER-2 oncogene play a role?

Musolino A, Bozzetti C, Bonomini S, Sammarelli G, Pezzuolo D, Bonati A, Ardizzoni A.

Lung Cancer. 2005 Dec;50(3):419-20. Epub 2005 Aug 26. No abstract available.

PMID:
16125820
19.

e6a2 BCR-ABL transcript in chronic myeloid leukemia: is it associated with aggressive disease?

Colla S, Sammarelli G, Voltolini S, Crugnola M, Sebastio P, Giuliani N.

Haematologica. 2004 May;89(5):611-3.

20.

Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia.

Colla S, Sammarelli G, Crugnola M, Ascani S, Sabbatini E, Bonomini S, Hojden M, Craviotto L, De Celis I, Morandi F, Caramatti C, Rizzoli V, Giuliani N.

Eur J Haematol. 2004 May;72(5):361-5. Review.

PMID:
15059073
21.

Hematologic malignancies with extramedullary spread of disease. Case 1. Multiple myeloma with extramedullary involvement of the pleura and testes.

Giuliani N, Caramatti C, Roti G, Geata A, Colla S, Bonomini S, Hojden M, La Monica S, Sammarelli G, Lazzaretti M, Craviotto L, Mangoni L, Rizzoli V.

J Clin Oncol. 2003 May 1;21(9):1887-8. No abstract available.

PMID:
12721268
22.

Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis.

Giuliani N, Colla S, Lazzaretti M, Sala R, Roti G, Mancini C, Bonomini S, Lunghi P, Hojden M, Genestreti G, Svaldi M, Coser P, Fattori PP, Sammarelli G, Gazzola GC, Bataille R, Almici C, Caramatti C, Mangoni L, Rizzoli V.

Blood. 2003 Jul 15;102(2):638-45. Epub 2003 Mar 20.

PMID:
12649156
23.

Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease.

Giuliani N, Colla S, Sala R, Moroni M, Lazzaretti M, La Monica S, Bonomini S, Hojden M, Sammarelli G, Barillè S, Bataille R, Rizzoli V.

Blood. 2002 Dec 15;100(13):4615-21. Epub 2002 Aug 8.

PMID:
12393684
24.

Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation.

Cilloni D, Carlo-Stella C, Falzetti F, Sammarelli G, Regazzi E, Colla S, Rizzoli V, Aversa F, Martelli MF, Tabilio A.

Blood. 2000 Nov 15;96(10):3637-43.

PMID:
11071665
25.

Selective expression and constitutive phosphorylation of SHC proteins [corrected] in the CD34+ fraction of chronic myelogenous leukemias.

Bonati A, Carlo-Stella C, Lunghi P, Albertini R, Pinelli S, Migliaccio E, Sammarelli G, Savoldo B, Tabilio A, Dall'Aglio PP, Pelicci PG.

Cancer Res. 2000 Feb 1;60(3):728-32. Erratum in: Cancer Res 2000 Mar 1;60(5):1472.

26.

Effects of the tyrosine kinase inhibitor AG957 and an Anti-Fas receptor antibody on CD34(+) chronic myelogenous leukemia progenitor cells.

Carlo-Stella C, Regazzi E, Sammarelli G, Colla S, Garau D, Gazit A, Savoldo B, Cilloni D, Tabilio A, Levitzki A, Rizzoli V.

Blood. 1999 Jun 1;93(11):3973-82.

PMID:
10339507
27.

New reciprocal translocation t(5;10)(q33;q22) associated with atypical chronic myeloid leukemia.

Siena S, Sammarelli G, Grimoldi MG, Schiavo R, Nozza A, Roncalli M, Mecucci C, Santoro A, Carlo-Stella C.

Haematologica. 1999 Apr;84(4):369-72.

28.

Primitive hematopoietic progenitors within mobilized blood are spared by uncontrolled rate freezing.

Cilloni D, Garau D, Regazzi E, Sammarelli G, Savoldo B, Caramatti C, Mangoni L, Rizzoli V, Carlo-Stella C.

Bone Marrow Transplant. 1999 Mar;23(5):497-503.

29.

CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF.

Cesana C, Carlo-Stella C, Regazzi E, Garau D, Sammarelli G, Caramatti C, Tabilio A, Mangoni L, Rizzoli V.

Bone Marrow Transplant. 1998 Mar;21(6):561-8.

30.

Reverse transcription polymerase chain reaction is a reliable assay for detecting leukemic colonies generated by chronic myelogenous leukemia cells.

Savoldo B, Sammarelli G, Dotti G, Garau D, Regazzi E, Cilloni D, Tabilio A, Rizzoli V, Carlo-Stella C.

Leukemia. 1998 Mar;12(3):434-40.

31.

Detection of breast cancer cells using the magnetic cell separation (MACS) system: implications for stem cell purging.

Garau D, Regazzi E, Savoldo B, Sammarelli G, Rizzoli V, Carlo-Stella C.

Eur J Histochem. 1997;41 Suppl 2:17-8. No abstract available.

PMID:
9859763
32.

In vitro growth of mobilized peripheral blood progenitor cells is significantly enhanced by stem cell factor.

Cesana C, Carlo-Stella C, Mangoni L, Regazzi E, Garau D, Sammarelli G, Caramatti C, Almici C, Rizzoli V.

Stem Cells. 1997;15(3):207-13.

33.

Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein.

Carlo-Stella C, Dotti G, Mangoni L, Regazzi E, Garau D, Bonati A, Almici C, Sammarelli G, Savoldo B, Rizzo MT, Rizzoli V.

Blood. 1996 Oct 15;88(8):3091-100.

PMID:
8874208
34.

Chromosome changes in lymphocytes of patients with scleroderma.

Casalone R, Granata P, Minelli E, Righi R, Meroni E, Mazzola D, Sammarelli G, Baratelli E, Broggini M.

Ann Genet. 1995;38(3):145-50.

PMID:
8540685

Supplemental Content

Loading ...
Support Center